Sino Biopharmaceutical Ltd
OTC:SBHMY
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
7.1864
20.16
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
SBHMY
stock under the Base Case scenario is
14.07
USD.
Compared to the current market price of 17.65 USD,
Sino Biopharmaceutical Ltd
is
Overvalued by 20%.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Sino Biopharmaceutical Ltd.
Fundamental Analysis
SBHMY Profitability Score
Profitability Due Diligence
Score
SBHMY Solvency Score
Solvency Due Diligence
Score
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Sino Biopharmaceutical Ltd
Balance Sheet Decomposition
Sino Biopharmaceutical Ltd
Sino Biopharmaceutical Ltd
Free Cash Flow Analysis
Sino Biopharmaceutical Ltd
| CNY | |
| Free Cash Flow | CNY |
Earnings Waterfall
Sino Biopharmaceutical Ltd
Wall St
Price Targets
SBHMY Price Targets Summary
Sino Biopharmaceutical Ltd
According to Wall Street analysts, the average 1-year price target for
SBHMY
is 25.51 USD
with a low forecast of 16.35 USD and a high forecast of 34.57 USD.
Dividends
Current shareholder yield for
Sino Biopharmaceutical Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
SBHMY
stock under the Base Case scenario is
14.07
USD.
Compared to the current market price of 17.65 USD,
Sino Biopharmaceutical Ltd
is
Overvalued by 20%.